DK377889A - Lactamderivater - Google Patents

Lactamderivater Download PDF

Info

Publication number
DK377889A
DK377889A DK377889A DK377889A DK377889A DK 377889 A DK377889 A DK 377889A DK 377889 A DK377889 A DK 377889A DK 377889 A DK377889 A DK 377889A DK 377889 A DK377889 A DK 377889A
Authority
DK
Denmark
Prior art keywords
group
4alkyl
hydrogen atom
6alkyl
phenyl
Prior art date
Application number
DK377889A
Other languages
English (en)
Other versions
DK169922B1 (da
DK377889D0 (da
Inventor
Ian Harold Coates
Alexander William Oxford
Peter Charles North
Barry John Price
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888818393A external-priority patent/GB8818393D0/en
Priority claimed from GB898904195A external-priority patent/GB8904195D0/en
Priority claimed from GB898904550A external-priority patent/GB8904550D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK377889D0 publication Critical patent/DK377889D0/da
Priority claimed from HU90608A external-priority patent/HU207078B/hu
Publication of DK377889A publication Critical patent/DK377889A/da
Application granted granted Critical
Publication of DK169922B1 publication Critical patent/DK169922B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
DK377889A 1988-08-02 1989-08-01 Substituerede (imidazol-4-yl)methylpyrido-, og -azepino-, indolonderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne DK169922B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8818393 1988-08-02
GB888818393A GB8818393D0 (en) 1988-08-02 1988-08-02 Chemical compounds
GB8904195 1989-02-23
GB898904195A GB8904195D0 (en) 1989-02-23 1989-02-23 Chemical compounds
GB898904550A GB8904550D0 (en) 1989-02-28 1989-02-28 Chemical compounds
GB8904550 1989-02-28
HU90608A HU207078B (en) 1988-08-02 1990-01-31 Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
HU60890 1990-01-31

Publications (3)

Publication Number Publication Date
DK377889D0 DK377889D0 (da) 1989-08-01
DK377889A true DK377889A (da) 1990-02-03
DK169922B1 DK169922B1 (da) 1995-04-03

Family

ID=27450153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK377889A DK169922B1 (da) 1988-08-02 1989-08-01 Substituerede (imidazol-4-yl)methylpyrido-, og -azepino-, indolonderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne

Country Status (14)

Country Link
EP (1) EP0353983B1 (da)
JP (1) JPH02160786A (da)
AT (1) ATE138659T1 (da)
AU (1) AU631131B2 (da)
CA (1) CA1336906C (da)
DE (1) DE68926553T2 (da)
DK (1) DK169922B1 (da)
ES (1) ES2088389T3 (da)
FI (1) FI92067C (da)
GR (1) GR3020349T3 (da)
IL (1) IL91167A (da)
NO (1) NO169714C (da)
NZ (1) NZ230154A (da)
PT (1) PT91336B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226032A (en) * 1987-09-03 1991-12-23 Glaxo Group Ltd 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
GB8904552D0 (en) 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical process
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
GB9011469D0 (en) * 1990-05-23 1990-07-11 Glaxo Group Ltd Chemical process
US5102889B1 (en) * 1990-09-27 1993-05-11 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US5229517A (en) * 1990-09-27 1993-07-20 Hoechst-Roussel Pharmaceuticals Incorporated 2-(4-Piperindinyl)-1H-pyrido[4,3-B]indol-1-ones and related compounds
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
GB9216154D0 (en) * 1992-07-30 1992-09-09 Glaxo Group Ltd Chemical compounds
EP0581388A1 (en) * 1992-07-30 1994-02-02 Glaxo Group Limited Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
CA2212092A1 (en) * 1995-12-01 1997-06-12 Makoto Shibata Pyrroloazepine derivatives
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
WO2003014118A1 (en) * 2001-08-08 2003-02-20 Pharmacia & Upjohn Company THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
US6770655B2 (en) 2002-01-18 2004-08-03 Aryx Therapeutics 5-HT3 receptor antagonists and methods of use
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
CA2629077C (en) 2005-11-16 2014-03-18 F. Hoffmann-La Roche Ag Novel process for the preparation of thoc
RU2007139634A (ru) * 2007-10-25 2009-04-27 Сергей Олегович Бачурин (RU) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
EP2424366B1 (en) 2009-04-29 2016-02-17 Medivation Technologies, Inc. Pyrido [4, 3-b]indoles and methods of use
EP2424364A4 (en) 2009-04-29 2012-12-19 Medivation Technologies Inc PYRIDO [4.3-B] INDOLES AND METHODS OF USE
ES2664599T3 (es) 2009-05-20 2018-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
BR112013021126A2 (pt) 2011-02-18 2019-09-24 Medivation Technologies Inc método para reduzir a pressão sanguínea, método para aumentar o fluxo sanguíneo renal ou diminuir a reabsorção de sódio, método para tratar uma doença, kit, composto e composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
NZ226032A (en) * 1987-09-03 1991-12-23 Glaxo Group Ltd 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
JPH02160786A (ja) 1990-06-20
FI893634A0 (fi) 1989-08-01
AU631131B2 (en) 1992-11-19
EP0353983A3 (en) 1990-07-25
FI893634A7 (fi) 1990-02-03
DE68926553T2 (de) 1996-10-17
CA1336906C (en) 1995-09-05
NO169714B (no) 1992-04-21
PT91336B (pt) 1995-05-04
ATE138659T1 (de) 1996-06-15
FI92067C (fi) 1994-09-26
NZ230154A (en) 1991-10-25
EP0353983A2 (en) 1990-02-07
DE68926553D1 (de) 1996-07-04
IL91167A0 (en) 1990-03-19
GR3020349T3 (en) 1996-09-30
DK169922B1 (da) 1995-04-03
ES2088389T3 (es) 1996-08-16
AU3918689A (en) 1990-02-08
NO169714C (no) 1992-07-29
NO893101D0 (no) 1989-08-01
NO893101L (no) 1990-02-05
PT91336A (pt) 1990-03-08
FI92067B (fi) 1994-06-15
IL91167A (en) 1993-06-10
DK377889D0 (da) 1989-08-01
EP0353983B1 (en) 1996-05-29

Similar Documents

Publication Publication Date Title
DK377889D0 (da) Lactamderivater
ATE111910T1 (de) Lactamderivate.
GB8904551D0 (en) Chemical compounds
ATE88714T1 (de) 2'-desoxy-5-fluoruridinderivate.
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
DE3872722D1 (de) Indol-derivate.
DK0458624T3 (da) Fremgangsmåde til fremstilling af lactamderivater
EP0327307A3 (en) Tricyclic ketone derivatives having a 5-HT3 antagonist activity
DK189389D0 (da) Heterotetracycliske lactamderivater
MY102646A (en) Tricyclic ketones
MY106232A (en) Lactam derivatives
FI892415A0 (fi) Tricykliska ketoner.
MY103831A (en) Lactam derivatives.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed